Open Studies
Available Clinical Trials
Browse our current portfolio of open trials. Partner doctors can apply to run any of these studies at their site — we handle the rest.
A Phase III Study of Novel SGLT2 Inhibitor in Type 2 Diabetes with Cardiovascular Risk
Evaluating the cardiovascular safety and glycemic efficacy of an investigational SGLT2 inhibitor in adults with T2DM and established cardiovascular disease or high CV risk.
Phase II Randomized Controlled Trial of Immunotherapy Combination in Advanced NSCLC
Investigating the safety and preliminary efficacy of a PD-1/CTLA-4 combination immunotherapy regimen in patients with advanced non-small cell lung cancer who have progressed on first-line therapy.
Observational Study of Digital Biomarkers in Early Parkinson's Disease
A prospective observational study using wearable sensors and smartphone-based assessments to identify digital biomarkers for early Parkinson's disease progression.
Phase III Study of Biologic Agent in Moderate-to-Severe Rheumatoid Arthritis
Evaluating the efficacy and safety of an investigational IL-6 receptor antagonist versus placebo in adults with moderate-to-severe RA who have had an inadequate response to methotrexate.
Phase II Study of Novel Antifibrotic Agent in Idiopathic Pulmonary Fibrosis
Assessing the safety, tolerability, and efficacy signals of an investigational antifibrotic compound in patients with IPF who are stable on standard of care.
Real-World Evidence Study: Cardiovascular Outcomes in Atrial Fibrillation
A large-scale real-world evidence study examining long-term cardiovascular outcomes in patients with non-valvular atrial fibrillation managed with oral anticoagulation therapy.
Don't See the Right Trial?
Our portfolio is constantly growing. Apply as a partner site and we'll match you with trials that fit your specialty and patient population as new studies open.
Apply as a Partner Site